These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 33730376)

  • 1. Transfer of triptans into human breast milk and estimation of infant drug exposure through breastfeeding.
    Amundsen S; Nordeng H; Fuskevåg OM; Nordmo E; Sager G; Spigset O
    Basic Clin Pharmacol Toxicol; 2021 Jun; 128(6):795-804. PubMed ID: 33730376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative aspects of triptans in treating migraine.
    Adelman JU; Lewit EJ
    Clin Cornerstone; 2001; 4(3):53-64. PubMed ID: 12739316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hair analysis for detection of triptans occasionally used or overused by migraine patients-a pilot study.
    Ferrari A; Baraldi C; Licata M; Vandelli D; Marchesi F; Palazzoli F; Verri P; Rustichelli C; Giuliani E; Silingardi E
    Eur J Clin Pharmacol; 2016 Sep; 72(9):1075-81. PubMed ID: 27245458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy.
    Tfelt-Hansen P; De Vries P; Saxena PR
    Drugs; 2000 Dec; 60(6):1259-87. PubMed ID: 11152011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of triptan tablet consumption per attack: a prospective study of migraineurs in Spain.
    Pascual J; Fité B; López-Gil A
    Headache; 2002 Feb; 42(2):93-8. PubMed ID: 12005301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of rizatriptan and other triptans on the nausea symptom of migraine: a post hoc analysis.
    Lipton RB; Pascual J; Goadsby PJ; Massiou H; McCarroll KA; Vandormael K; Jiang K; Lines CR
    Headache; 2001 Sep; 41(8):754-63. PubMed ID: 11576198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current and emerging second-generation triptans in acute migraine therapy: a comparative review.
    Deleu D; Hanssens Y
    J Clin Pharmacol; 2000 Jul; 40(7):687-700. PubMed ID: 10883409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of use of triptans and reasons for switching them in a tertiary care migraine population.
    Sheftell FD; Feleppa M; Tepper SJ; Volcy M; Rapoport AM; Bigal ME
    Headache; 2004; 44(7):661-8. PubMed ID: 15209687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy of triptans for the abortive treatment of migraine: a multiple treatment comparison meta-analysis.
    Thorlund K; Mills EJ; Wu P; Ramos E; Chatterjee A; Druyts E; Goadsby PJ
    Cephalalgia; 2014 Apr; 34(4):258-67. PubMed ID: 24108308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rizatriptan: a pharmacoeconomic review of its use in the acute treatment of migraine.
    McCormack PL; Foster RH
    Pharmacoeconomics; 2005; 23(12):1283-98. PubMed ID: 16336021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational migraine management: optimising treatment with the triptans.
    Millson DS
    Funct Neurol; 2000; 15 Suppl 3():182-91. PubMed ID: 11200789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of rizatriptan and other triptans on stringent measures of efficacy.
    Adelman JU; Lipton RB; Ferrari MD; Diener HC; McCarroll KA; Vandormael K; Lines CR
    Neurology; 2001 Oct; 57(8):1377-83. PubMed ID: 11673575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials.
    Ferrari MD; Roon KI; Lipton RB; Goadsby PJ
    Lancet; 2001 Nov; 358(9294):1668-75. PubMed ID: 11728541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical use of triptans in the management of migraine].
    Lantéri-Minet M
    CNS Drugs; 2006; 20 Spec no.1():12-23. PubMed ID: 16841523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of triptans for pediatric migraines.
    Eiland LS; Hunt MO
    Paediatr Drugs; 2010 Dec; 12(6):379-89. PubMed ID: 21028917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triptans for the management of migraine.
    Johnston MM; Rapoport AM
    Drugs; 2010 Aug; 70(12):1505-18. PubMed ID: 20687618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug dependence associated with triptans and ergot derivatives: a case/non-case study.
    Beau-Salinas F; Jonville-Béra AP; Cissoko H; Bensouda-Grimaldi L; Autret-Leca E
    Eur J Clin Pharmacol; 2010 Apr; 66(4):413-7. PubMed ID: 20024536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of triptans for migraine headaches during pregnancy and breastfeeding.
    Duong S; Bozzo P; Nordeng H; Einarson A
    Can Fam Physician; 2010 Jun; 56(6):537-9. PubMed ID: 20547518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials.
    Ferrari MD; Goadsby PJ; Roon KI; Lipton RB
    Cephalalgia; 2002 Oct; 22(8):633-58. PubMed ID: 12383060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of the sustained pain-free plus no adverse events endpoint in clinical trials of triptans in acute migraine.
    Dodick DW; Sandrini G; Williams P
    CNS Drugs; 2007; 21(1):73-82. PubMed ID: 17190530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.